India's Gland Pharma gains on upbeat quarterly results

Gland Pharma

06/08/2025 05:02

** India's Gland Pharma GLAD.NS climbs as much as 6.4%; last up 1.9% at 1,999.70 rupees

** Drugmaker reports higher Q1 profit, driven by a production recovery at European unit Cenexi

** Stock top gainer on pharma index .NIPHARM, which is down 0.9%

** Scale up at Cenexi, upcoming U.S. launches will drive revenue growth through FY26, say Nomura analysts

** Nomura raises PT on GLAD to 2,010 rupees from 1,570 rupees, maintains "neutral"

** Goldman Sachs says Cenexi "surprised positively", raises FY26-28 EPS estimates by 5%-6% to factor in Q1 results

** Avg rating on GLAD at "hold"; median PT is 1,787 rupees - data compiled by LSEG

** YTD, GLAD up 12% vs a 7% decline in pharma index

 (Reporting by Kashish Tandon in Bengaluru)

 ((Kashish.tandon@thomsonreuters.com))